US Patent Issued to Sanofi on April 29 for "Anti-GPRC5D antibodies and compositions" (French Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,475, issued on April 29, was assigned to Sanofi (Paris).

"Anti-GPRC5D antibodies and compositions" was invented by Elisabeth Remy (Paris), Klervi Desrumeaux (Paris), Helene Bonnevaux (Paris), Marco Meloni (Paris), Angela Virone-Oddos (Paris) and Marielle Chiron Blondel (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides antigen-binding proteins specifically binding GPRC5D, as well as respective antibodies in enhanced ADCC formats, and methods of using them to treat cancers such as multiple myeloma."

The patent was filed on July 31, 2024, under Application No. 18/790,955.

*For further information, including images, ...